arrow
M

Matthew J. Ahearne

university of leicester
H指数:16
被引数:976

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase IIa study of the anti-PD-L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL-T trial

avelumab抗PD-L1抗体在复发/难治性PTCL中的IIa期研究:AVAIL-T试验

2026-09-200
OAAI
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications

Glofitamab和Epcoritamab在真实世界中的疗效、耐受性及实际意义:一项英国多中心回顾性分析

BLOOD
IF23.1
2024-11-051
PRE
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse
2023-11-302
OA
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

通过抗体检测预测免疫功能低下人群的新型冠状病毒肺炎感染风险

LANCET
IF88.5
2023-07-015
OAAI
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

在b细胞恶性肿瘤中接种两剂和三剂疫苗后对SARS-CoV-2变体的免疫反应: 英国普罗塞奥研究

2022-03-2457
OAAI
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort
2021-05-264
OAAI
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery
2020-08-0637
OAAI
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia
2019-11-2918
OAAI